Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
Hutchinson-Gilford progeria syndrome (HGPS), a rare premature aging disorder that leads to death at an average age of 14.7 years due to myocardial infarction or stroke, is caused by mutations in the <i>LMNA</i> gene. Nearly 90% of HGPS cases carry the G608G mutation within exon 11 that g...
Main Authors: | Chang Liu, Rouven Arnold, Gonçalo Henriques, Karima Djabali |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/10/1276 |
Similar Items
-
Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells
by: Rouven Arnold, et al.
Published: (2021-07-01) -
Impact of MnTBAP and Baricitinib Treatment on Hutchinson–Gilford Progeria Fibroblasts
by: Elena Vehns, et al.
Published: (2022-07-01) -
Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
by: Ramona Hartinger, et al.
Published: (2023-05-01) -
Nuclear Pore Complexes Cluster in Dysmorphic Nuclei of Normal and Progeria Cells during Replicative Senescence
by: Jennifer M. Röhrl, et al.
Published: (2021-01-01) -
Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria
by: Alexandre Chojnowski, et al.
Published: (2015-08-01)